- Jun 28, 2018
- Good manufacturing practice (GMP) training course was held.
- Apr 02, 2018
- Chiba university hospital has been posted as a precision inspection facility for LCAT deficiency syndrome by Japanese society for inherited metabolic diseases.
- Dec 21, 2017
- PRTIMES reported our clinical research on gene therapy for familial LCAT deficiency syndrome and its approval by MHLW.
- Jul 18, 2017
- Good manufacturing practice (GMP) training course was held.
- Sep 01, 2016
- Sankei Shimbun and Chiba Nippo reported our clinical research on gene therapy for familial LCAT deficiency syndrome and its approval by MHLW.
- Aug 24, 2016
- Nikkan Kogyo Shimbun and Yakuji Nippo reported our clinical research on gene therapy for familial LCAT deficiency syndrome and its approval by MHLW.
- Aug 08, 2016
- Our clinical research on gene therapy for familial LCAT deficiency syndrome, classified as Class I Regenerative Medicine, approved by MHLW.
- Jul 18, 2016
- Good manufacturing practice (GMP) training course was held.
- Jul 01, 2015
- LCAT deficiency syndrome became specified as an intractable disease.
- Jun 02, 2015
- Good manufacturing practice (GMP) training course was held.
- May 13, 2015
- Patient enrollment is completed for NKT cell based immunotherapy for non-small cell lung cancer.
- Jun 26, 2014
- Good manufacturing practice (GMP) training course was held.
- Mar 18, 2014
- Articles on our research, “Immunotherapy using NKT cells” were published in Tokyo Shimbun.
- Mar 11, 2014
- Articles on our research, “Immunotherapy using NKT cells” were published in Chunichi Shimbun.
